DKSH, the leading Market Expansion Services provider with a focus on Asia, has been certified ISO 13485 for its operation in Macau. The certification recognizes DKSH’s comprehensive quality management system for medical devices.
HONG KONG, Jan. 7, 2015 /PRNewswire/ — DKSH Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, is being awarded the ISO 13485 certification only months after entering the Macau market through the acquisition of The Glory Medicina Lda (Glory).
ISO 13485 is an International Organization for Standardization (ISO) standard, published in 2003, that represents requirements for a comprehensive quality management system for design and manufacturing of medical devices. The primary objective of ISO 13485 is to facilitate harmonized medical device regulatory requirements for quality management.
"Since we entered Macau in early 2014, we have invested heavily in establishing processes that support our expansion plans and clients’ growth in this rapidly developing market. SAP is fully live and this certification is another confirmation of our ability to offer a high-level quality management system to healthcare companies in Macau," said Richard Holloway, Vice President, Business Unit Healthcare, DKSH Hong Kong. He added, "I am glad that Glory which has been acquired by DKSH less than a year ago, has already been fully integrated into the DKSH Group."
Being awarded for ISO 13485 in Macau further strengthens DKSH’s market position and contributes to the Group’s reputation as the leading Market Expansion Services provider with focus on Asia.
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 735 business locations in 35 countries — 710 of them in Asia — and 27,200 specialized staff, DKSH generated net sales of CHF 9.6 billion in 2013.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices. With 150 business locations in 14 countries and around 9,180 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales of around CHF 4.3 billion in 2013.